Aridis Pharmaceuticals, Inc.
ARDSDrugs in Pipeline
3
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
Frequently asked questions
What is in Aridis Pharmaceuticals, Inc.'s drug pipeline?→
CatalystAlert tracks 3 drug candidates in Aridis Pharmaceuticals, Inc.'s (ARDS) pipeline across Phase 3, Phase 2. Its lead program is AR-301 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Aridis Pharmaceuticals, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Aridis Pharmaceuticals, Inc. (ARDS) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track ARDS biotech catalysts?→
Add ARDS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Aridis Pharmaceuticals, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.